Skip to content
  • HOME
  • ABOUT

    CPA is the leading national, bipartisan organization exclusively representing domestic producers and workers across many industries and sectors of the U.S. economy.

    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    • ABOUT CPA
    • STAFF
    • BOARD
    • CONTACT CPA
    LEARN MORE ➔
  • ISSUES

    CPA ADVOCACY ISSUES

    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • NEWSROOM
    May Trade Deficit of $106.4 Billion is Not as Bad as it Looks

    May Trade Deficit of $106.4 Billion is Not as Bad as it Looks

    July 8, 2026

    THE LATEST

    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY

    May Trade Deficit of $106.4 Billion is Not as Bad as it Looks

    Minimum Import Price: The Good American Tradition Versus the Failed Globalist Design

    New Report Reveals China’s Plan to Dominate the Global Space Market, Supported by U.S. Investor Dollars

    Report: China’s Capture of Latin American Space Sectors

    MORE FROM THE NEWSROOM ➔
  • RESEARCH
  • CONTRIBUTE

    Help us take the next steps to strengthen America's domestic producers.

    Your generous contribution will enable us to keep fighting for the prosperous growth of an industrial strategy in many sectors such as Healthcare, Agriculture, Manufacturing, Trade, Technology & Tax.

    CONTRIBUTE TODAY ➔

India Drug Maker Aurobindo Keeps Getting Poor Grades by the FDA

Archive, commentary, Commentary Featured, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaDecember 15, 2022Leave a comment

One of India’s pharmaceutical labs has run afoul of the FDA many times this year. The U.S. is dependent on foreign labs like Aurobindo for its drug supply. Can the government help change that?

BARDA Industry Day: More Money for American Pharma?

Archive, CPA News, Featured Home Page, Healthcare, Issues, Manufacturing, NewsroomBy Kenneth RapozaNovember 17, 2022Leave a comment

A project out of the Department of Health & Human Services promises more domestic supply of locally made vaccines and critical drugs. Will they finally deliver?

China’s Ever-Expanding Orwellian State is a Warning to the US – Congressional Hearing

Featured Home Page, Capital Markets, China, CPA News, Customs, Healthcare, Issues, NewsroomBy Kenneth RapozaNovember 16, 2022Leave a comment

The Congressional-Executive Commission on China hears testimony about Zero Covid and the human rights abuses its exacerbated in the world’s No. 2 economy. In a report by the Commission, calls for more capital market sanctions.

Here’s How Pharmaceutical Drugs Are Recalled. And Why Some Might Still Remain on the Shelves.

Featured Home Page, Archive, commentary, Commentary Featured, Healthcare, Issues, NewsroomBy CPA NewsroomNovember 3, 2022Leave a comment

Most people think that when a drug is recalled by the lab, it is pulled from pharmacy shelves. It’s not. Here’s how drug recalls really work.

China’s Five-Year Plan for Biotech Making it Increasingly Attractive for Global Pharma

Archive, China, commentary, Commentary Featured, Featured Home Page, Healthcare, Issues, Manufacturing, NewsroomBy Kenneth RapozaAugust 26, 2022Leave a comment

The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.

FDA Advancements Act Passes Committee, Sets Stage for Fall Reauthorization Passage

Archive, CPA News, Featured Home Page, Healthcare, Issues, Manufacturing, NewsroomBy Kenneth RapozaJune 15, 2022Leave a comment

The FDA Safety and Landmark Advancements (FDASLA) Act has passed a key committee, with 25 out of some 30 amendments passing. Generics and baby formula crisis got most of the attention.

CPA Questions FDA Commissioner on Faulty Data on Indian Generic Drugs

Press Release, HealthcareBy CPA NewsroomJune 2, 2022Leave a comment

WASHINGTON — The Coalition for a Prosperous America (CPA) today sent a letter to Dr. Robert Califf, Commissioner of the Food and Drug Administration (FDA),

FDA’s Updated Drug Shortage List Loaded with Critical Medicines

Archive, CPA News, Featured Home Page, Healthcare, Issues, NewsroomBy Kenneth RapozaJune 1, 2022Leave a comment

The Food and Drug Administration recently updated its drug shortage list. More than half of the updates include drugs on the essential medicines list.

Senate Puts FDA Re-authorization Deal in Jeopardy Over Infant Formula Crisis

Featured Home Page, Archive, Healthcare, Issues, Supply ChainBy Kenneth RapozaMay 26, 2022Leave a comment

Senator Burr warned the FDA that until the Senate is okay with their response to the infant formula crisis, and present a plan to prevent it in the future, the Generic Drug User Fee Authorization bill might be put on hold.

CPA Urges President Biden to Address Decades of Failure by the FDA

Press Release, Healthcare, IssuesBy CPA NewsroomMay 25, 2022Leave a comment

WASHINGTON — The Coalition for a Prosperous America (CPA) urged President Joe Biden to address the decades of dereliction of duty by the Food and

←1
23456
…7891011…
12
13→
  • ABOUT
  • NEWSROOM
  • CONTACT
Facebook-f Youtube Linkedin

© 2026 COALITION FOR A PROSPEROUS AMERICA. ALL RIGHTS RESERVED.

Go to Top

⋆ ⋆ ⋆ MENU

  • HOME
  • ABOUT
    • ABOUT CPA
    • STAFF
    • BOARD
    • ADVOCACY
    • MEMBERSHIP
    • HISTORY
    • OUR MISSION
    • OUR VISION
    • CONTACT US
  • ISSUES
    • AGRICULTURE
    • BUY AMERICAN
    • CHINA
    • CURRENCY
    • DE MINIMIS
    • HEALTHCARE
    • MANUFACTURING
    • RENEWABLE ENERGY
    • TAX
    • TECHNOLOGY
    • TRADE & TARIFFS
  • RESEARCH
  • NEWSROOM
    • THE LATEST
    • NEWSLETTER: PROSPER WEEKLY
    • PRESS RELEASES
    • CPA OPINION
    • LETTERS & TESTIMONY
  • CONTRIBUTE
Prosper Weekly

DON'T MISS IT!

Subscribe to CPA's exclusive weekly Newsletter ➔

 Share This
 Facebook
 LinkedIn
 Copy

Share on Mastodon